Benutzerspezifische Werkzeuge

Curriculum Vitae - Prof. Dr. med. Veit Roessner

 

Education and Employment 

 

Honors and Awards 

Editorial service (peer review journals, selection)
Member of Editorial Board for

Selected other scientific activities 

Scientific Advisory Board of the German Tourette Society, Scientific Advisory Board of the German Society for Obsessive-Compulsive Disorder; German Association for Child and Adolescent Psychiatry and Psychotherapy (DGKJP), European Society for Study of Tourettes Syndrome (ESSTS), European Network of Research on Hyperkinetic Disorders (EUNETHYDIS), ECNP Networks Initiative, Member of Advisory Board of the Journal for Children and Adolescent Medicine

Research Funding (past 5 yrs):

About 4.2 Mio Euros (e.g. EU, DFG, BMBF, Friede Springer Stiftung, Roland Ernst Stiftung, Else-Kröner-Fresenius-Stiftung, GBA Innovations-fonds, Sächsisches Staatsministerium für Soziales und Verbraucherschutz etc.)

h-Index: 43; citations past 10 yrs: 6846

Top10 Publications

  • Giller F, Aggensteiner PM, Banaschewski T, Döpfner M, Brandeis D, Roessner V, Beste C: Affective dysregulation in children is associated with difficulties in response control in emotionally ambiguous situations. Biol Psychiatry CNNI. 2021; Doi:10.1016/j.bpsc.2021.03.014 IF 5.335
  • Jarczok TA, Roebruck F, Pokorny L, Biermann L, Roessner V, Klein C, Bender S: Single-Pulse TMS to the Temporo-Occipital and Dorsolateral Prefrontal Cortex Evokes Lateralized Long Latency EEG Responses at the Stimulation Site. Front. Neurosci. 2021; Doi:10.3389/fnins.2021.616667 IF 4.154
  • Bluschke A, Schreiter ML, Friedrich J, Adelhöfer N, Roessner V, Beste C: Neurofeedback trains a superordinate system relevant for seemingly opposing behavioral control deficits depending on ADHD subtype. Dev Sci. 2020;23:e12956. Doi:10.1111/desc.12956 IF 3.880
  • Buse J, Schoenefeld K, Münchau A, Roessner V. Neuromodulation in tourette syndrome: dopamine and beyond. Neurosci Biobehav Rev. 2013;37(6):1069-1084. Doi:10.1016/j.neubiorev.2012.10.004 IF 10.284
  • Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M … Roessner V. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013;38(1):12-23. Doi:10.1016/j.psyneuen.2012.09.017 IF 5.137
  • Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy. 2010;65(12):1506-1524. Doi:10.1111/j.1398-9995.2010.02449.x IF 6.297
  • Achenbach T, Becker A, Döpfner M, Goodman R … Roessner V et al. Multicultural assessment of child and adolescent psychopathology with the ASEBA and SDQ instruments: research findings, applications, and future directions. J Child Psychol Psychiatry. 2008;49(3):251-275. Doi:10.1111/j.1469-7610.2007.01867.x  IF 4.854
  • Roessner V, Freeman R, Becker A, Banaschewski T, Rothenberger A. Developmental psychopathology in children with chronic tic disorders with/without ADHD – new insights. Eur Child Adolesc Psychiatry. 2007;16(Suppl1):24-35. Doi:10.1007/s00787-007-1004-6 IF 1.992
  • Banaschewski T, Roessner V, Dittmann R W, Santosh P J, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004;13(Suppl1):102-116. Doi:10.1007/s00787-004-1010-x IF 1.167
  • Becker A, Hagenberg N, Roessner V, Woerner W, Rothenberger A. Evaluation of the self-reported SDQ in a clinical setting: do self-reports tell us more than ratings by adult informants? Eur Child Adolesc Psychiatry. 2004;13(Suppl2):17-24. Doi:10.1007/s00787-004-2004-4 IF 1.167